SANTINI, DANIELE
 Distribuzione geografica
Continente #
NA - Nord America 1.105
AS - Asia 564
EU - Europa 403
SA - Sud America 168
Continente sconosciuto - Info sul continente non disponibili 53
AF - Africa 50
Totale 2.343
Nazione #
US - Stati Uniti d'America 1.068
SG - Singapore 218
BR - Brasile 135
VN - Vietnam 107
IT - Italia 98
CN - Cina 94
RU - Federazione Russa 79
SE - Svezia 51
HK - Hong Kong 47
IE - Irlanda 46
DE - Germania 28
BD - Bangladesh 27
CI - Costa d'Avorio 27
FR - Francia 26
IN - India 25
UA - Ucraina 23
CA - Canada 18
GB - Regno Unito 17
FI - Finlandia 13
IQ - Iraq 8
MX - Messico 8
AR - Argentina 7
ID - Indonesia 7
VE - Venezuela 7
ZA - Sudafrica 7
CO - Colombia 5
DZ - Algeria 5
EC - Ecuador 5
MY - Malesia 5
NL - Olanda 5
TR - Turchia 5
CW - ???statistics.table.value.countryCode.CW??? 4
HN - Honduras 4
MA - Marocco 4
PL - Polonia 4
SV - El Salvador 4
AT - Austria 3
BO - Bolivia 3
CL - Cile 3
JP - Giappone 3
LT - Lituania 3
NP - Nepal 3
PY - Paraguay 3
SA - Arabia Saudita 3
TN - Tunisia 3
AZ - Azerbaigian 2
DK - Danimarca 2
KR - Corea 2
PR - Porto Rico 2
TH - Thailandia 2
BF - Burkina Faso 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
PK - Pakistan 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 2.294
Città #
Ashburn 271
Singapore 129
Chandler 86
San Jose 67
Dublin 46
Hong Kong 46
Fairfield 44
New York 32
Ho Chi Minh City 31
Council Bluffs 30
Dallas 30
Boardman 28
Hanoi 28
The Dalles 28
Abidjan 27
Beijing 26
Jacksonville 25
Houston 21
Princeton 21
Lawrence 20
Lauterbourg 17
Turin 17
Los Angeles 16
Moscow 13
Munich 13
San Diego 13
Seattle 13
Milan 12
Wilmington 12
Washington 11
Chennai 9
Milwaukee 9
Woodbridge 9
Santa Clara 8
São Paulo 8
Turku 8
Buffalo 7
Cambridge 7
London 7
Montreal 7
Arlington 6
Rio de Janeiro 6
Ann Arbor 5
Boston 5
Chicago 5
Da Nang 5
San Mateo 5
Baghdad 4
Denver 4
Haiphong 4
Helsinki 4
Johannesburg 4
Macerata 4
Naples 4
Orem 4
San Salvador 4
Warsaw 4
Willemstad 4
Columbus 3
Curitiba 3
Frankfurt am Main 3
Hefei 3
La Paz 3
Mexico City 3
Mumbai 3
Palermo 3
Paris 3
Phoenix 3
Porto Alegre 3
Quito 3
San Francisco 3
Shanghai 3
Tokyo 3
Toronto 3
Aparecida de Goiânia 2
Aracaju 2
Atlanta 2
Barranquilla 2
Belo Horizonte 2
Bragança Paulista 2
Brooklyn 2
Bến Tre 2
Cagliari 2
Calgary 2
Casablanca 2
Contagem 2
Culiacán 2
Eelde 2
Guangzhou 2
Guaratinguetá 2
Hải Dương 2
Jaú 2
Joinville 2
La Plata 2
Lagoa Santa 2
Manchester 2
Marche 2
Miano 2
Mountain View 2
Nasiriyah 2
Totale 1.433
Nome #
Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients 171
Outcomes of advanced gastric cancer patients treated with at least three lines of systemic chemotherapy 146
Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma 145
Percutaneous management of bone metastases: state of the art, interventional strategies and joint position statement of the Italian College of MSK Radiology (ICoMSKR) and the Italian College of Interventional Radiology (ICIR) 141
Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? 127
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: There is a sense in antisense? 122
Role of STAT3 pathway in genitourinary tumors 119
Second-line treatment efficacy and toxicity in older vs. non-older patients with advanced gastric cancer: A multicentre real-world study 118
Prognostic vs predictive molecular biomarkers in colorectal cancer: Is KRAS and BRAF wild type status required for anti-EGFR therapy? 114
Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623 108
A phase II trial of fixed-dose rate gemcitabine plus capecitabine in metastatic/advanced biliary tract cancer patients 107
Dilemma in metastatic colorectal cancer: VEGF versus EGRF targeting 103
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study 100
What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis 99
Prognostic relevance of objective response according to EASL criteria and mRECIST criteria in hepatocellular carcinoma patients treated with loco-regional therapies: A literature-based meta-analysis 95
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 94
Germline copy number variation in the YTHDC2 gene: Does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility? 94
The role of cMET in non-small cell lung cancer resistant to EGFR-Inhibitors: Did we really find the target? 91
Imatinib dose escalation versus sunitinib as a second line treatment in KIT exon 11 mutated GIST: A retrospective analysis 89
Driver mutations and differential sensitivity to targeted therapies: A new approach to the treatment of lung adenocarcinoma 82
Predicting efficacy and toxicity in the era of targeted therapy: Focus on anti-EGFR and anti-VEGF molecules 78
Totale 2.343
Categoria #
all - tutte 13.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022121 0 0 0 0 1 3 0 4 35 16 41 21
2022/2023273 20 28 34 10 15 33 1 12 68 1 43 8
2023/2024196 26 5 19 24 29 59 2 8 0 1 14 9
2024/2025432 29 24 5 10 23 55 86 20 69 16 36 59
2025/20261.028 95 47 47 74 129 62 172 101 86 74 89 52
2026/2027139 12 32 18 77 0 0 0 0 0 0 0 0
Totale 2.343